Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Haller

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2007
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT GroupDaniel J Sargent, Smitha Patiyil, Greg Yothers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2004
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysisLeonard L Gunderson, Daniel J Sargent, Joel E Tepper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints DatabaseWinson Y Cheung, Lindsay A Renfro, David Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trialsDaniel J Sargent, Harry S Wieand, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2008
Potential regional differences for the tolerability profiles of fluoropyrimidinesDaniel G Haller, Jim Cassidy, Stephen J Clarke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancerNeil E Martin, Thomas B Brunner, Krystina D Kiel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2025
Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive DatabaseJean-Baptiste Bachet, Aimery de Gramont, Morteza Raeisi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144Stephen R Smalley, Jacqueline K Benedetti, Stephen K Williamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2017
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)Charles S Fuchs, Donna Niedzwiecki, Harvey J Mamon, et al.
Journal of the National Cancer Institute|August 25, 2020
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT DatabaseAnna D Wagner, Axel Grothey, Thierry Andre, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2007
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT GroupDaniel J Sargent, Smitha Patiyil, Greg Yothers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2004
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysisLeonard L Gunderson, Daniel J Sargent, Joel E Tepper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints DatabaseWinson Y Cheung, Lindsay A Renfro, David Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trialsDaniel J Sargent, Harry S Wieand, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2008
Potential regional differences for the tolerability profiles of fluoropyrimidinesDaniel G Haller, Jim Cassidy, Stephen J Clarke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancerNeil E Martin, Thomas B Brunner, Krystina D Kiel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2025
Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive DatabaseJean-Baptiste Bachet, Aimery de Gramont, Morteza Raeisi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144Stephen R Smalley, Jacqueline K Benedetti, Stephen K Williamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2017
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)Charles S Fuchs, Donna Niedzwiecki, Harvey J Mamon, et al.
Journal of the National Cancer Institute|August 25, 2020
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT DatabaseAnna D Wagner, Axel Grothey, Thierry Andre, et al.
Pageof 12